[HTML][HTML] How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: an expert opinion by IMIDs study group
F Ferretti, R Cannatelli, M Benucci… - Frontiers in …, 2021 - frontiersin.org
Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and
daily routine around the world. Huge efforts from pharmacological industries have led to the …
daily routine around the world. Huge efforts from pharmacological industries have led to the …
[HTML][HTML] The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
G Damiani, A Pacifico, F Pelloni… - Journal of the European …, 2021 - ncbi.nlm.nih.gov
Letters to the Editor e645 scanty. We present 5 cases (from 4 different centres) of bullous
pemphigoid (BP)–respectively of pemphigus vulgaris (PV)–all confirmed by clinical …
pemphigoid (BP)–respectively of pemphigus vulgaris (PV)–all confirmed by clinical …
Sequential doxycycline and colchicine combination therapy in Covid-19: the salutary effects
Abstract Coronavirus virus disease 2019 (COVID-19) is a viral infectious disease caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually considered as …
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually considered as …
Skin manifestations of COVID‐19 in children: part 3
D Andina, A Belloni‐Fortina, C Bodemer… - Clinical and …, 2021 - academic.oup.com
The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress …
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress …
[HTML][HTML] Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care
In less than four months, an unprecedented pandemic changed the world scenario, closing
institutions and commerce, paralyzing sports championships, blocking frontiers, and putting …
institutions and commerce, paralyzing sports championships, blocking frontiers, and putting …
Covid‐19 pandemic and the skin
K Drenovska, E Schmidt… - International journal of …, 2020 - Wiley Online Library
In the beginning of the COVID‐19 outbreak, skin manifestations, if present, were not paid
enough attention. Then, the focus moved toward the impact of the prolonged use of personal …
enough attention. Then, the focus moved toward the impact of the prolonged use of personal …
[HTML][HTML] Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic
Updated international expert recommendations for the management of autoimmune bullous
diseases during the COVID&# x02010; 19 p unknown since only few cases of AA and early …
diseases during the COVID&# x02010; 19 p unknown since only few cases of AA and early …
[HTML][HTML] Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre-including this research content-immediately …
available on the COVID-19 resource centre-including this research content-immediately …
[HTML][HTML] COVID-19 outbreak and autoimmune bullous diseases: a systematic review of published cases
M Kasperkiewicz - Journal of the American Academy of …, 2021 - ncbi.nlm.nih.gov
REFERENCES 1. Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review
and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am …
and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am …